Daiwa Securities Group
OLMA icon

Daiwa Securities Group’s Olema Pharmaceuticals OLMA Stock Holding History

Daiwa Securities Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-224
Closed -$6K – 1363
2025
Q4 		$6K Hold
224
– – ﹤0.01% 1224
2025
Q3 		$2K Hold
224
– – ﹤0.01% 1278
2025
Q2 		$1K Hold
224
– – ﹤0.01% 1272
2025
Q1 		$1K Hold
224
– – ﹤0.01% 1239
2024
Q4 		$1K Hold
224
– – ﹤0.01% 1261
2024
Q3 		$3K Hold
224
– – ﹤0.01% 1200
2024
Q2 		$2K Hold
224
– – ﹤0.01% 1256
2024
Q1 		$3K Hold
224
– – ﹤0.01% 1243
2023
Q4 		$3K Buy
+224
New +$3.01K ﹤0.01% 1250
2022
Q4 		– Sell
-118
Closed – – 1359
2022
Q3 		$0 Hold
118
– – ﹤0.01% 1371
2022
Q2 		$0 Hold
118
– – ﹤0.01% 1406
2022
Q1 		$1K Hold
118
– – ﹤0.01% 1321
2021
Q4 		$1K Buy
+118
New +$2.44K ﹤0.01% 1347

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Daiwa Securities Group's OLMA Position: Q1 2026 in Review

Daiwa Securities Group sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 224 shares — an estimated $6K sold.

Daiwa Securities Group first reported a position in OLMA in Q4 2021 and held it in 13 quarters. The position peaked at $6K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Daiwa Securities Group reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 224 Olema Pharmaceuticals shares in Q1 2026, an estimated $6K.
  • Daiwa Securities Group first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 13 quarters.
  • Daiwa Securities Group's Olema Pharmaceuticals position peaked at $6K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.